Le Lézard
Classified in: Health

Renowned Non-Surgical Rhinoplasty Specialist, Dr. Alexander Rivkin, Introduces Liquid Rhinoplasty with Permanent Results

Dr. Alexander Rivkin is world-renowned for his non-surgical rhinoplasty techniques, and now Dr. Rivkin offers his patients a 15-minute non-surgical nose job that provides permanent results without incisions and downtime.

LOS ANGELES, June 7, 2023 /PRNewswire-PRWeb/ -- Many individuals seek rhinoplasty to improve the aesthetic appearance of their noses. They may feel self-conscious about a nose that they perceive as too large, crooked, asymmetrical, or with a hump or bump. Rhinoplasty can reshape and refine the nose, creating a more harmonious facial balance and boosting self-confidence. Traditionally, rhinoplasty involved invasive surgery to reshape the nose.

In recent years, there has been a noticeable shift towards non-surgical procedures. Patients appreciate the reduced downtime, shorter recovery period, and decreased risks associated with these non-invasive techniques. Unlike traditional surgical rhinoplasty, which involves reshaping the nasal structures through incisions and removal of cartilage or bone, Dr. Rivkin's non-surgical rhinoplasty focuses on adding volume and reshaping the nose using injectable dermal fillers. By strategically using dermal fillers, Dr. Rivkin corrects minor imperfections, improves symmetry, and restores facial harmony.

Dermal fillers are typically composed of hyaluronic acid, a substance naturally found in the body that helps to hydrate and plump the skin. Dr. Rivkin, renowned for his extensive experience in performing liquid rhinoplasties, sought to find a way to prolong the effects of this procedure. As a result, he began incorporating PMMA fillers, such as Bellafill and Artefill, into his practice. What sets these fillers apart is their composition. Unlike hyaluronic acid-based fillers, PMMA fillers consist of polymethylmethacrylate microspheres suspended in a collagen-like gel. These microspheres provide a longer-lasting solution as they are not absorbed by the body and remain in place, contributing to the sustained aesthetic improvements desired by patients. The unique properties of PMMA fillers make them an excellent choice for individuals seeking a non-surgical rhinoplasty option with enduring results.

This recent advancement in non-surgical rhinoplasty makes this procedure even more enticing to individuals seeking nasal aesthetic improvements. In a groundbreaking new article published, Dr. Rivkin, the first author, reviews the outcomes of numerous patients who underwent non-surgical rhinoplasty using permanent fillers. This comprehensive study follows their journeys and highlights the long-term effectiveness and patient satisfaction achieved through this innovative procedure.

Dr. Rivkin's development of non-surgical rhinoplasty has offered a less invasive option for individuals seeking nose enhancements, providing them with a safer, quicker, and more accessible alternative to surgical procedures.

"I am thrilled to introduce this groundbreaking 15-minute non-surgical rhinoplasty technique, which offers a game-changing solution to those seeking nasal enhancement," said Dr. Alexander Rivkin. "By combining my expertise in facial aesthetics with the latest advancements in injectable fillers, I can now provide patients with a minimally invasive alternative that yields permanent and beautiful results."

In addition to its efficiency and permanence, Dr. Rivkin's non-surgical rhinoplasty procedure offers other notable advantages. These include reduced risk of complications, no visible scarring, minimal discomfort during and after the procedure, and the ability to make further adjustments if desired. Furthermore, patients can resume their daily activities immediately following the treatment, without the need for lengthy downtime.

Dr. Rivkin's innovative approach has gained significant recognition in the medical community, and his expertise has been sought after by patients worldwide. With his commitment to patient safety and satisfaction, Dr. Rivkin continues to push the boundaries of cosmetic medicine, helping individuals achieve their desired aesthetic goals without the need for invasive surgery.

More about Dr. Alexander Rivkin:

Dr. Alexander Rivkin is a highly respected cosmetic physician specializing in non-surgical facial enhancements. With his extensive knowledge, technical skill, and artistic approach, Dr. Rivkin has transformed the field of cosmetic medicine. He is recognized for his pioneering work in non-surgical rhinoplasty, having perfected the procedure over years of experience and research. Dr. Rivkin is committed to delivering exceptional results while prioritizing patient safety and satisfaction.

Dr. Rivkin is a facial aesthetic specialist and an assistant clinical professor at the David Geffen / UCLA School of Medicine. He received his undergraduate degree from Columbia University, medical degree from the Yale University School of Medicine and residency in Otolaryngology/ Head and Neck Surgery at the University of California San Diego School of Medicine. His practice, RIVKIN Aesthetics, is focused on developing and perfecting non-invasive, non-ablative cosmetic treatments. He is widely known for pioneering and popularizing the non-surgical rhinoplasty procedure, and in 2020 published the largest statistically comprehensive study on non-surgical rhinoplasty in medical literature. Dr. Rivkin divides his time between patient care, clinical research, physician education, media appearances and lectures throughout the world. RIVKIN Aesthetics is located at 435 N Roxbury Dr #100 in Beverly Hills, CA 90210 and 11645 Wilshire Blvd., Suite 800 in Los Angeles, CA. For more information, please visit http://www.westsideaesthetics.com or call 310-443-5273.

Media Contact

Lyuba Buklemisheva, RIVKIN Aesthetics, 310-443-5273, Lyuba@westsideaesthetics.com



These press releases may also interest you

23 sep 2023
The flow diversion aneurysm treatment market size is expected to grow by USD 2.11 billion from 2022 to 2027. In addition, the momentum of the market will be progressing at a CAGR of  8.8% during the forecast period, according to Technavio Research....

23 sep 2023
The dietary supplements market size is expected to grow by USD 61.4 billion from 2022 to 2027, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 8.16% during the forecast period. Increasing adoption of...

23 sep 2023
African Union Heads of State and Government, global health leaders and development partners...

23 sep 2023
In the news release, Public-sector contract talks - Tens of thousands demonstrate in Montréal to defend public services, issued 23-Sep-2023 by Alliance du personnel professionnel et technique de la santé et des services sociaux (APTS) over PR...

23 sep 2023
More than 7,500 participants took a giant step forward for youth mental health today, crossing the finish line for the 11th anniversary of RBC Race for the Kids in Toronto. Collectively they raised $2.5 million in support of Family Navigation Project...

23 sep 2023
On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to participate in the YL201 Phase I/II Investigators Meeting hosted by Suzhou MediLink Therapeutics Co., Ltd. The...

News published on and distributed by: